Acrivon Therapeutics (ACRV) Accumulated Depreciation (2021 - 2026)
Acrivon Therapeutics' Accumulated Depreciation was $4.11 million in Q2 2026, up 57.4% from $2.61 million a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Accumulated Depreciation (2021 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Depreciation at Acrivon Therapeutics came in at $3.32 million, up 69.1% from FY2024.
- Accumulated Depreciation has now increased for four consecutive years, with a four-year compound annual growth rate of 177.4% (FY2021 to FY2025).
- In earlier years, Accumulated Depreciation was $1.96 million in FY2024 (+105.2%), $956,000 in FY2023 (+127.6%), $420,000 in FY2022 (+650.0%) and $56,000 in FY2021.
- The Q2 2026 figure marks the highest quarterly Accumulated Depreciation in data going back to Q4 2021.
- Compared with a year earlier, Accumulated Depreciation has increased for 12 straight quarters, with growth averaging 82.0% over the last eight quarters.
- The year-over-year growth in Accumulated Depreciation has ranged between 57.4% (Q2 2026) and 650.0% (Q4 2022) over the last five years.
- Per Business Quant data, ACRV's Accumulated Depreciation in the three quarters before Q2 2026 was $3.7 million (Q1 2026), $3.32 million (Q4 2025) and $2.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Acrivon Therapeutics | 87.84 Mn | 87.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.11 Mn |
| Mar 31, 2026 | 3.70 Mn |
| Dec 31, 2025 | 3.32 Mn |
| Sep 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.61 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 956,000.00 |
| Sep 30, 2023 | 807,000.00 |
| Jun 30, 2023 | 674,000.00 |
| Mar 31, 2023 | 545,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Sep 30, 2022 | 295,000.00 |
| Dec 31, 2021 | 56,000.00 |
API Access
Acrivon Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();